Pharmacy in Heart and Lung Transplant: The Latest Studies in Journal Watch
Published 26 January 2026
The first Journal Watch of 2026 explores topics in transplant pharmacy. Issue editor Colleen Hutchinson, PharmD, BCCP, gathers topics including:
- The NUDT16 genotype, and if it predicts development of neutropenia in lung transplant recipients receiving valganciclovir for CMV
- Daratumumab monotherapy: can it desensitize patients awaiting heart transplant?
- Early mammalian target of rapamycin inhibitor (mTORi) initiation with reduced tacrolimus for renal sparing in heart transplant recipients
Issue Junior Editor:
Colleen Hutchinson, PharmD, BCCPCleveland Clinic
Cleveland, OH USA
Contributors:
Xinqi Liu, PharmD, BCTXP
Thomas Jefferson University Hospital
Philadelphia, PA USA
Kevin Reininger, PharmD, BCTXP
Mayo Clinic
Phoeniz, AZ USA
Devi Surajbali, PharmD
Tampa General Hospital
Tampa, FL USA
Journal Watch Senior Editor
Ross Thomson, BA, BMBCh, MRCP
ISHLT Journal Watch is a periodic publication presented by the ISHLT Early Career and Trainee Committee. Are you an early career professional and looking to contribute to an upcoming issue of Journal Watch? Send an email to communications@ishlt.org for more information on how to participate.

